Citadel Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Citadel Advisors’s Portfolio BCAT Stock Details BCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$309K	Sell	19,405 -70,731	-78%	-$1.09M	﹤0.01%	11053
2026 Q1	$1.27M	Buy	90,136 +72,687	+417%	+$1.07M	﹤0.01%	7131
2025 Q4	$247K	Buy	+17,449	New	+$252K	﹤0.01%	10575
2025 Q2	–	Sell	-11,331	Closed	-$163K	–	12560
2025 Q1	$163K	Sell	11,331 -3,280	-22%	-$50.1K	﹤0.01%	10738
2024 Q4	$221K	Buy	+14,611	New	+$235K	﹤0.01%	10266
2024 Q3	–	Sell	-34,255	Closed	-$562K	–	14241
2024 Q2	$562K	Buy	+34,255	New	+$551K	﹤0.01%	7822

Other funds holding BCAT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citadel Advisors's BCAT Position: Q2 2026 in Review

Citadel Advisors reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 78% in Q2 2026, selling an estimated $1.09M and leaving 19,405 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #11053.

Citadel Advisors first reported a position in BCAT in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.27M in Q1 2026. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

Citadel Advisors held 19,405 shares of BlackRock Capital Allocation Term Trust worth $309K as of Q2 2026.
Citadel Advisors sold 70,731 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $1.09M.
BlackRock Capital Allocation Term Trust made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11053 holding.
Citadel Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2024 and has held it in 6 quarters since.
Citadel Advisors's BlackRock Capital Allocation Term Trust position peaked at $1.27M in Q1 2026.
110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.